We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

73 hedge funds and large institutions have $55.6M invested in IVERIC bio, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more call options, than puts

Call options by funds: $566K | Put options by funds: $169K

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

3% more funds holding

Funds holding: 7173 (+2)

5% less capital invested

Capital invested by funds: $58.3M → $55.6M (-$2.67M)

21% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 24

Holders
73
Holders Change
+2
Holders Change %
+2.82%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
19
Reduced
24
Closed
9
Calls
$566K
Puts
$169K
Net Calls
+$397K
Net Calls Change
+$360K
Name Holding Trade Value Shares
Change
Change in
Stake
GCP
26
GSA Capital Partners
United Kingdom
$330K -$282K -102,201 -46%
BCM
27
Bridgeway Capital Management
Texas
$307K +$311K +112,600 New
SXL
28
Summit X LLC
Missouri
$255K +$34.6K +12,534 +16%
AIM
29
Alambic Investment Management
California
$228K -$114K -41,411 -33%
Northern Trust
30
Northern Trust
Illinois
$203K
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$196K +$47.6K +17,241 +32%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$194K +$66.2K +24,000 +51%
BIM
33
Bogle Investment Management
Massachusetts
$177K -$373K -135,180 -68%
JP Morgan Chase
34
JP Morgan Chase
New York
$168K +$170K +61,493 New
US Bancorp
35
US Bancorp
Minnesota
$154K -$22.6K -8,200 -13%
Creative Planning
36
Creative Planning
Kansas
$148K
Bank of New York Mellon
37
Bank of New York Mellon
New York
$136K -$12.3K -4,443 -8%
State Street
38
State Street
Massachusetts
$121K -$43.7K -15,826 -26%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$119K
Goldman Sachs
40
Goldman Sachs
New York
$114K -$196 -71 -0.2%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$102K -$115K -41,742 -53%
Wells Fargo
42
Wells Fargo
California
$102K +$5.72K +2,075 +6%
Rockefeller Capital Management
43
Rockefeller Capital Management
New York
$100K +$101K +36,540 New
II
44
Inspire Investing
Idaho
$94K +$25.5K +9,249 +37%
ARTA
45
A.R.T. Advisors
New York
$83K -$291K -105,608 -78%
PAM
46
Panagora Asset Management
Massachusetts
$72K -$10.7K -3,896 -13%
OSAM
47
O'Shaughnessy Asset Management
Connecticut
$65K -$23.8K -8,623 -27%
CSS
48
Cubist Systematic Strategies
Connecticut
$64K +$64.8K +23,500 New
GF
49
Gabelli Funds
New York
$55K +$5.52K +2,000 +11%
Citadel Advisors
50
Citadel Advisors
Florida
$48K +$48.2K +17,483 New

ISEE Hedge Fund Activity: Q2 2018 in Review

73 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2018, worth a combined $55.6M — down 4.6% from $58.3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ISEE positions and 9 closed out — a net gain of 2 holders — while 19 added to existing stakes and 24 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $3.61M. The largest seller was Armistice Capital, exiting entirely with an estimated $9.84M sold.

  • 73 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2018, up from 71 in Q1 2018.
  • Funds reported $55.6M of IVERIC bio, Inc. Common Stock stock for Q2 2018, down 4.6% quarter-over-quarter.
  • 11 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2018 and 9 closed out, a net change of +2 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2018 was Sabby Management, an estimated $3.61M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2018 was Armistice Capital, an estimated $9.84M sold.

Based on aggregated 13F filings for Q2 2018.